Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Vimian Group AB ( (SE:VIMIAN) ) has issued an update.
Vimian Group AB has successfully issued EUR 150 million in senior unsecured bonds, significantly oversubscribed, with plans to list them on Nasdaq Stockholm. This move reflects strong investor confidence and is expected to enhance Vimian’s financial flexibility, supporting its growth in the animal health sector.
The most recent analyst rating on (SE:VIMIAN) stock is a Buy with a SEK55.00 price target. To see the full list of analyst forecasts on Vimian Group AB stock, see the SE:VIMIAN Stock Forecast page.
More about Vimian Group AB
Vimian is a global animal health company specializing in Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Headquartered in Stockholm, Sweden, it serves over 17,000 veterinary clinics and laboratories across more than 80 markets, with 1,200 employees and annual revenues of approximately EUR 375 million.
Average Trading Volume: 396,570
Current Market Cap: SEK20.07B
For an in-depth examination of VIMIAN stock, go to TipRanks’ Stock Analysis page.